日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

ID2 通过抑制转录因子 TCF3 的活性来抑制多发性骨髓瘤细胞增殖。

Fulciniti Mariateresa, Yao Yao, Perini Tommaso, Fong Ng Jessica, Schavgoulidze Anaïs, Deng Shuhui, Cui Jian, Encinas Mayoral Jessica, Ladisa Francesco, Young Ryan M, Epstein Charles B, White Cassandra M, Ott Christopher J, Gulla Annamaria, Matulis Shannon M, Sperling Adam S, Morelli Eugenio, Boise Lawrence H, Binder Moritz, Szalat Raphael, Samur Mehmet K, Anderson Kenneth C, Munshi Nikhil C

Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2Rα

抗原-IL-2 CAR增强子驱动CAR-T细胞的命运和干性,增强其在各种模型中的抗肿瘤疗效,且该作用独立于IL-2Rα。

Moravej, Heydar; Rakhshandehroo, Taha; Khan, Radia M M; Rivet, Victoria Marie; Marcandalli, Elodie; Mantri, Shreya R; Taklifi, Pegah; Lee, Uk-Jae; Louis, Benjamin B V; Munaretto, Leila A; Regan, Kathryn; Farkash, Zoe; Berland, Lea; Gabr, Zeina; Wolff, Alexandra N; Kowalewski, Antonia; Allen, Harris H; Nili, Ali; Baral, Jessika; Mercadante, Dayna; Fulciniti, Mariateresa; Jacobson, Caron A; Sperling, Adam S; Nadeem, Omar; Nia, Hadi T; Hemann, Michael; Munshi, Nikhil C; Rashidian, Mohammad

Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation.

扩大可成药锌指蛋白组,可以明确药物诱导降解的特性

Słabicki Mikołaj, Park Jiho, Nowak Radosław P, Roy Burman Shourya S, Pellman Jesse, Zou Charles, Razumkov Hlib, Carreiro Jeannie, Rastogi Simran, Goldstein Anna, Nagiec Marek M, Donovan Katherine A, Che Jianwei, Hunkeler Moritz, Geng Qixiang, Hsu Chi-Lin, Lakshminarayan Megha, Shu Chelsea, Zon Rebecca L, Kozicka Zuzanna, Park Paul M C, Tsai Jonathan M, Yoon Hojong, Jones Lyn H, Sperling Adam S, Gray Nathanael S, Fischer Eric S, Ebert Benjamin L

Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis

卡非佐米在复发或难治性多发性骨髓瘤中的处方模式和疗效:一项真实世界分析

Dong, Sharlene; Banerjee, Rahul; Khan, Adeel M; Wang, Mengru; Wang, Xiaoliang; Afghahi, Anosheh; Afrough, Aimaz; Janakiram, Murali; Wang, Bo; Cowan, Andrew J; Sperling, Adam S; Anderson, Larry D Jr; Rajkumar, S Vincent; Kaur, Gurbakhash

Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy

接受BCMA CAR T细胞疗法治疗的复发/难治性多发性骨髓瘤患者发生侵袭性真菌病的情况很少见。

Little, Jessica S; Medina Pena, Angelica; Kim, E Bridget; Yee, Andrew J; Nadeem, Omar; Midha, Shonali; Sperling, Adam S; Munshi, Nikhil C; Raje, Noopur; Frigault, Matthew J; Cirstea, Diana D; Hammond, Sarah P

Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma

桥接强度与多发性骨髓瘤 BCMA CAR-T 疗法后造血功能恢复受损相关

Frenking, Jan H; Zhou, Xiang; Rejeski, Kai; Wagner, Vivien; Costello, Patrick; Hielscher, Thomas; Gatti, Lilan; Kauer, Joseph; Nadeem, Omar; Mai, Elias K; Michel, Christian S; Friedrich, Mirco J; Sedloev, David; Weinhold, Niels; Goldschmidt, Hartmut; Herfarth, Klaus; Schmitt, Anita; Hundemer, Michael; Schmitt, Michael; Müller-Tidow, Carsten; Topp, Max; Einsele, Hermann; Dreger, Peter; Munshi, Nikhil C; Sperling, Adam S; Rasche, Leo; Sauer, Sandra; Raab, Marc S

Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platform.

利用综合药物发现平台鉴定PPM1D小分子抑制剂

Shaw Subrata, Jiang Wei, Rush Jason, Dumont Nancy, Kim John, Singh Ritu, Skepner Adam, Khodier Carol, Raffier Cerise, Murphy Zachary, Yan Ni, Schluter Cameron, Yu Xiao, Szuchnicki Mateusz, Sathappa Murugappan, Kahn Josephine, Sperling Adam S, Wagner Florence, McKinney David C, Gould Alexandra E, Garvie Colin W, Miller Peter G

Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML

在KMT2A-r和NPM1c AML的临床前模型中,美西格胺单独使用或与menin抑制剂联合使用均有效。

Bourgeois, Wallace; Cutler, Jevon A; Aubrey, Brandon J; Wenge, Daniela V; Perner, Florian; Martucci, Cynthia; Henrich, Jill A; Klega, Kelly; Nowak, Radosław P; Donovan, Katherine A; Boileau, Meaghan; Wen, Yanhe; Hatton, Charlie; Apazidis, Athina A; Olsen, Sarah Naomi; Kirmani, Nadia; Pikman, Yana; Pollard, Jessica A; Perry, Jennifer A; Sperling, Adam S; Ebert, Benjamin L; McGeehan, Gerard M; Crompton, Brian D; Fischer, Eric S; Armstrong, Scott A

SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation

SRCAP突变通过表观遗传和DNA修复失调驱动克隆性造血

Chen, Chun-Wei; Zhang, Linda; Dutta, Ravi; Niroula, Abhishek; Miller, Peter G; Gibson, Christopher J; Bick, Alexander G; Reyes, Jaime M; Lee, Yi-Tang; Tovy, Ayala; Gu, Tianpeng; Waldvogel, Sarah; Chen, Yi-Hung; Venters, Bryan J; Estève, Pierre-Olivier; Pradhan, Sriharsa; Keogh, Michael-Christopher; Natarajan, Pradeep; Takahashi, Koichi; Sperling, Adam S; Goodell, Margaret A

Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

关于前驱期多发性骨髓瘤最佳临床试验设计的圆桌讨论

Ghobrial, Irene M; Gormley, Nicole; Kumar, Shaji K; Mateos, Maria-Victoria; Bergsagel, P Leif; Chesi, Marta; Dhodapkar, Madhav V; Dispenzieri, Angela; Fonseca, Rafael; Getz, Gad; Kastritis, Efstathios; Kristinsson, Sigurdur Y; Martinez-Climent, Jose Angel; Manier, Salomon; Marinac, Catherine R; Maura, Francesco; Morgan, Gareth J; Davies, Faith E; Nadeem, Omar; Nuvolone, Mario; Paiva, Bruno; O'Donnell, Elizabeth; Prosper, Felipe; Shah, Urvi A; Sklavenitis-Pistofidis, Romanos; Sperling, Adam S; Vassiliou, George S; Munshi, Nikhil C; Castle, Philip E; Anderson, Kenneth C; San Miguel, Jesus F